Gonococcal urethritis cases among with earlier MSM cases.
Reductions in rates of sexually transmit ted diseases (STDs) among men who have sex with men (MSM) followed the advent of the HIV epidemic in the United States. Reports from several US cities documented a sharp de cline in gonorrhea among MSM during the early 1980s, [1] [2] [3] coincident with reports of re ductions in unsafe sexual behaviors. 4, 5 How ever, several recent reports suggest a reversal in these trends. Investigators in Seattle reported increases in syphilis, gonorrhea, and chla mydial infection among MSM from 1997 through 1999. 6, 7 Cases of rectal gonorrhea among MSM in San Francisco increased as the proportion of MSM practicing unprotected anal intercourse rose. 8 Through the Gonococcal Isolate Surveil lance Project (GISP) of the Centers for Dis ease Control and Prevention (CDC), we eval uated trends in gonococcal infection among MSM. GISP is a sentinel surveillance project implemented in 1986 to monitor national trends in antimicrobial resistance in Neisseria gon orrhoeae through the collection of urethral gonococcal isolates from selected STD clin ics nationwide. As a systematic sample of gonococcal isolates from men attending pub lic and military STD clinics in the United States, GISP also provides a unique source of national epidemiologic data on gonorrhea. We analyzed GISP data to assess characteristics of MSM with gonorrhea from 1992 through 1999.
Methods

Project Design
The first 25 urethral isolates of N gonor rhoeae from male patients were collected each month at selected public and military STD clin ics. GISP was initiated in 1986; however, be cause significant changes in participating clin ics occurred before 1992, the analysis period for this project was limited to 1992 through 1999. 
Statistical Analysis
Data analyses were performed with SAS version 6.12 (SAS Institute, Cary, NC). Esti mated total numbers of MSM gonococcal ure thritis cases in selected clinics were calculated by multiplying the proportion of GISP cases that involved MSM by the total number of gon orrhea cases among males reported each month in each clinic, and then summing the monthly numbers to produce annual estimates. Esti mates were produced for clinics and years in which total numbers of gonorrhea cases among males were reported for at least 11 of 12 months; the year's monthly average was used to interpolate the missing data value. Cases of gonococcal urethritis from MSM were com pared with cases from heterosexual men, and MSM cases in 1995 through 1999 were com pared with MSM cases in 1992 through 1994. Distributions of demographic and clinical char acteristics and resistance phenotypes were com pared by the χ 2 test. The Fisher exact test was used when an expected value was less than 5.
Medians and geometric means were compared by the Kruskal-Wallis test for 2 groups.
Results
Of 36 509 GISP cases from 1992 through 1999, 34 942 (95.7%) reported sexual orienta tion data and 8.3% of these (2908 of 34 942) were MSM. The proportion of cases involving MSM increased from 4.5% (219 of 4858) in 1992 to 13.2% (591 of 4465, P< .001) in 1999. In 9 clinics (Chicago, Denver, Honolulu, Long Beach, Orange County, Portland, San Diego, Seattle, and San Francisco), more than 5% of cases each year involved MSM; these clinics accounted for more than 80% of MSM cases each year. Among these clinics, the 1999 pro portions of cases involving MSM ranged from 11.3% in Chicago to 56.8% in San Francisco ( Figure 1 ). Among the remaining clinics, the proportion of cases involving MSM increased from 1.3% in 1992 to 2.8% in 1999. For 7 clin ics, estimated total numbers of MSM gonor rhea cases could be calculated for 5 to 7 years each ( Figure 2 ). In 6 of these clinics, the num ber was fewer than 150 cases in each year, while San Francisco had more than 500 estimated total cases of gonorrhea among MSM for 1998. Trends in estimated total numbers of MSM cases were similar to the trends in proportions shown in Figure 1 . 
Comparison of MSM Cases and Heterosexual Cases
Individuals in MSM cases were older than those in heterosexual cases, with median ages of 30 and 25 years, respectively (P < .001) ( Table 1) . A higher proportion of MSM than of heterosexuals were non-Hispanic Whites (59.5% vs 7.3%), and a lower proportion were non-Hispanic Blacks (21.3% vs 78.6%, P = .001). Similar proportions of MSM and het erosexuals were symptomatic (97.3% and 96.8%, respectively) and attended the clinic as volunteers (95.3% and 94.5%, respectively) or as contacts of known gonorrhea cases (3.8% and 4.2%, respectively). MSM were more likely than heterosexuals to have ever had gon orrhea previously (50.7% vs 46.8%, P< .001) but were less likely to have had gonorrhea in the past 12 months (16.5% vs 18.9%, P=.003). Among those who had had at least 1 episode of gonorrhea in the past 12 months, MSM and heterosexuals alike had a median of 1 episode (range=1-10) and a mean of 1.4 episodes.
Isolates with high MICs of erythromycin (MIC ≥ 2.0 µg/mL) were far more prevalent among MSM than among heterosexuals 
Comparison of MSM Cases in 1992-1994 and 1995-1999
Of the 2908 MSM cases, 695 (23.9%) oc curred during the early part of the project pe riod (1992-1994) and 2213 (76.1%) occurred during the more recent part of the project pe riod (1995) (1996) (1997) (1998) (1999) . Early MSM cases were sim ilar to recent MSM cases in race/ethnicity dis tribution and proportion with symptoms (Table 2) . MSM in recent cases were slightly older than those in early cases (median age of 31 years vs 30 years, P =.005) and were more likely than those in early cases to attend the clinic as a contact of an individual with a known case of gonorrhea (4.2% vs 2.5%, P = .04). Similar proportions of MSM in recent and early cases reported that they had ever had gonor rhea previously (50.0% vs 53.0%), but a higher proportion of recent cases involved MSM who had had an episode of gonorrhea during the past 12 months (17.8% vs 12.4%, P = .002). Among MSM with at least 1 episode of gon orrhea in the past 12 months, early and recent cases did not differ in the mean (1.4) or me dian (1) number of episodes during that time.
Isolates with high MICs of erythromycin (MIC ≥ 2.0 µg/mL) were far more prevalent among recent MSM cases than among early MSM cases (12.0% vs 2.1%, P < .001). The geometric mean MIC of erythromycin for iso lates from recent cases was higher than that for isolates from early cases (0.55 µg/mL vs 0.41 µg/mL, P < .001).
When young MSM (aged <30 years) were compared with older MSM, changes in reason for attending clinic, previous episodes of gon orrhea, and erythromycin susceptibilities were similar for the periods 1992 to 1994 and 1995 to 1999 (data not shown). 1992-1994 and 1995-1999 Heterosexual cases were similar over time in race/ethnicity distribution, proportion with symptoms, reason for attending the clinic, his tory of ever having had gonorrhea, and num ber of episodes of gonorrhea in the past year. Individuals in recent heterosexual cases were slightly older than those in early cases (median age of 26 years vs 24 years, P < .001). In con trast to the trends seen with MSM cases, a smaller proportion of recent than of early het erosexual cases involved individuals who had had an episode of gonorrhea during the past 12 months (18.0% vs 20.2%, P< .001), and the geometric mean MIC of erythromycin for iso lates from recent cases was lower than that from early cases (0.25 µg/mL vs 0.27 µg/mL, P<.001). The proportion of heterosexual cases with high MICs of erythromycin did not change over time.
Comparison of Heterosexual Cases in
Discussion
National gonorrhea rates began to decline during the 1970s and continued to do so through 1997. 12 During the 1990s, however, increases in rates of gonorrhea and other STDs among MSM were documented in 2 US cities. [6] [7] [8] Our data demonstrate that increases in gonorrhea among MSM have occurred across a broad geographic area, including many cities on the West Coast. Most MSM affected are White, and they tend to be older than hetero sexual gonorrhea patients. Additionally, MSM with gonorrhea are increasingly likely to ac quire repeat gonococcal infections and to be infected with strains having high MICs of erythromycin. These findings highlight the additional knowledge that may be gained from a sur veillance system designed for a separate pur pose. GISP was established to monitor anti microbial resistance in N gonorrhoeae, but as a long-standing, systematic sample of gonococcal isolates from men through which demographic and clinical data are also col lected, GISP provides a unique opportunity to examine epidemiologic trends in gonor rhea as well.
These data have several limitations. First, GISP is a surveillance system and so relies on data gathered during routine public health ac tivities; not all clinics collected information on sexual orientation, and the manner of collect ing these data was subject to local variation. In particular, MSM of color may be less likely than White MSM to self-identify as gay or bi sexual and so may be underrepresented in our data. 13 However, if biases in reporting of sexual orientation were consistent over time, the over all trends are most likely valid. Second, GISP collects a systematic sample of urethral gon orrhea cases from each site, with the number of cases sampled per month constant over time. This sampling method allows measurement of percentages of urethral cases that involved MSM but does not allow direct measurement of the total number of MSM gonorrhea cases.
When calculations to derive estimates for these totals are made, underestimation of MSM cases may occur: GISP percentages are derived from urethral cases, whereas the total number of cases per month includes rectal and pharyngeal cases, which occur more frequently in MSM. Nonetheless, for the clinics and time periods for which estimates were possible, pro portional increases in MSM cases reflected increases in estimated case numbers. In addi tion, local investigations in 1997 determined that absolute increases in MSM gonorrhea cases had occurred in several GISP clinics. 14 Finally, GISP clinics are a convenience sam ple of STD clinics in the United States, cho sen to enhance the likelihood of detecting antimicrobial-resistant organisms. These lo cations may not reflect trends among MSM in other geographic areas or among MSM who seek care in other clinical settings. Changes in health care-seeking behaviors among MSM could affect trends measured in GISP. Changes in the participating clinics before 1992 led us to limit analysis to the years 1992 through 1999. Of note, the overall proportion of cases that were from MSM was relatively stableranging from 3.9% to 4.6%-before 1992 (CDC, unpublished data, 2000).
MSM were more likely than heterosexu als, and increasingly likely over time, to have isolates with high (≥2.0 µg/mL) MICs of eryth romycin. Such isolates frequently carry alter ations in the mtr locus, which encodes an efflux pump enhancing the organism's ability to resist a variety of hydrophobic molecules, including some antibiotics and the fecal lipids and bile salts present in the rectum. 15, 16 Such alterations give these gonococci a survival advantage in the rectum. The increase in urethral isolates with high erythromycin MICs among MSM is there fore consistent with reports of increases in rec tal gonorrhea and unprotected anal intercourse. These isolates may have a survival advantage among MSM, and their increasing prevalence may be contributing to the spread of gonor rhea among MSM.
Increases in gonococcal urethritis among MSM occurred in the context of declining over all gonorrhea rates until 1998; in that year, gon orrhea rates increased by more than 10% in 21 states, including 2 (Illinois and Oregon) with notable increases in gonorrhea among MSM in our project. 17 The overall gonorrhea rate in creased by an additional 1.2% in 1999. 18 In creases in gonorrhea among MSM may have contributed to overall increases in reported gonorrhea in some states; however, increases among women also occurred, and several states reported changes in screening and reporting practices that could have increased reported numbers of cases. 17 The increasing percent ages of urethral gonorrhea cases involving MSM was most striking in the West. This may have 2 explanations. First, there may be a rel atively greater persistence of heterosexual trans mission of gonorrhea in other geographic areas. Second, absolute increases in the number of cases of gonorrhea among MSM were docu mented in several West Coast cities. 14 The MSM with gonorrhea in this proj ect were older and more often White than the heterosexuals with gonorrhea, and these characteristics did not change over time. In particular, gonorrhea occurred as often among MSM older than 30 years as among those in their teens and 20s. Several studies have identified high prevalences of risk be haviors among young MSM. [19] [20] [21] However, our data are consistent with the findings, re ported in a study of a recent outbreak of syphilis among older MSM in Seattle, that risky practices are not limited to young MSM. 6 Gonococcal urethritis has a short incuba tion period and is usually symptomatic in men, making it useful as an indicator of recent un safe sexual behaviors. The increases in gono coccal infection among MSM documented here suggest increasing rates of unsafe sexual behavior. Indeed, local investigations of the in creases in gonorrhea among MSM in Portland, San Francisco, and Seattle in 1997 found that many cases were linked to attendance at se lected nightclubs and bathhouses and to sexual activity with anonymous partners. 14 Other re cent studies have found increases in recruit ment of anonymous partners 22 and increases in unprotected anal intercourse. 8, 23 Possible explanations for increases in risky sexual behaviors among MSM have been re cently outlined. 6 Fatigue with safe sex mes sages and practice may lead to relapses in behaviors, 22 while optimism about new therapies may reduce fear of acquiring and transmitting HIV infection. 24, 25 Risky sexual behaviors may directly increase the potential for infection with HIV and N gonorrhoeae. Additionally, prospec tive epidemiologic studies showing that gon orrhea in women 26 and men 27 is temporally as sociated with increased risk of acquiring HIV infection, and virologic studies showing that gonococcal urethritis is associated with in creased urethral shedding of cell-associated HIV DNA in urethral secretions and with in creased concentrations of HIV RNA in semen, 28 strongly suggest that gonorrhea fa cilitates HIV transmission. Efforts to identify appropriate and effective interventions to pro mote safe sex and reduce STDs among MSM are critical as the HIV epidemic continues.
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